Long-term mortality after gastric bypass surgery.

By T. Adams, Richard E. Gress, Sherman C. Smith, R. Halverson, S. Simper, W. Rosamond, M. LaMonte, A. Stroup, Steven Hunt. New England Journal of Medicine, 2007

2,564 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/2908f0ef315574fb7fa5a7941c97091a7fddd012

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. J. Himpens
2. B. Spiegelman

In Surgery

1. L. Angrisani
2. J. Himpens
3. B. Spiegelman
4. R. Eckel

Citations in the corpus

• Health Benefits of Gastric Bypass Surgery after 6 Years (2012, neutral): “Incidence Diabetes 0/299 0 (0-0) 7/290 2 (0-4) 12/255 5 (1-9) 36/207 17 (10-24) 14/213 7 (2-12) 31/207 15 (9-21)”
• Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Me (2019, background): “R61. (2013). Folic acid supplementation (400 to 800 μg/ day) should be part of a routine multivitamin-multimineral preparation (Grade B; BEL 2) and must be supplemented further (1,000 μg/day) when a deficiency state is suspected (e.”
• Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial (2018, methodology): “Trial Design, Participants, and Interventions The study design, rationale, and methods, including operative techniques, have been reported.(3,4) The complete study protocol (Supplement 1) was approved by institutional ethics committees, andwritten informedconsentwasobtained from all patients.”
• 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. (2022, background): “Similar results were demonstrated in a large retrospective study comparing 9949 individuals who had undergone RYGB compared with nonsurgical controls [139].”
• Morbidity and mortality associated with obesity. (2017, background): “The cause-specific mortality rate in the surgery group decreased by 56% for coronary artery disease, by 92% for diabetes, and by 60% for cancer (114).”
• Molecular mechanisms of cancer development in obesity (2011, background): “Data from bariatric surgery (for example, gastric bypass for weight loss) studies suggest that weight loss after surgery is associated with a reduced incidence of cance”
• Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes (2012, neutral): “Requiring hospitalization 4 (9) 11 (22) 4 (8)”
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, background): “Bariatric surgery improves or eliminates comorbid disease in most patients and improves long-term survival and death from CVD and malignancy, the two most common causes of death in NAFLD.((192-195)) Although there are no RCTs of bariatric surgery in NASH (and unlikely to be in the future), there are”